Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Whitehawk Therapeutics, Inc. (WHWK) had Cash Flow from Financial Activities of $95.20M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.14M |
|
$73.02M |
|
$0.76M |
|
$6.38M |
|
$22.36M |
|
$-15.22M |
|
$88.23M |
|
$73.02M |
|
$-14.43M |
|
$73.02M |
|
$73.02M |
|
$73.02M |
|
$-14.43M |
|
$-15.22M |
|
$-15.14M |
|
39.64M |
|
39.93M |
|
$1.84 |
|
$1.83 |
|
| Balance Sheet Financials | |
$232.61M |
|
$0.03M |
|
$1.39M |
|
$234.00M |
|
$12.27M |
|
-- |
|
-- |
|
$12.27M |
|
$221.73M |
|
$221.73M |
|
$221.73M |
|
46.78M |
|
| Cash Flow Statement Financials | |
$-11.86M |
|
$115.50M |
|
|
Cash Flow from Financial Activities |
$95.20M |
$28.73M |
|
$227.57M |
|
$198.84M |
|
$1.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.36% |
|
-212.99% |
|
-212.99% |
|
-- |
|
1021.92% |
|
1021.92% |
|
$-12.41M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
32.93% |
|
32.93% |
|
31.20% |
|
32.93% |
|
$4.74 |
|
$-0.31 |
|
$-0.30 |
|